Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer.

Autor: Hingorani SR; Fred Hutchinson Cancer Research Center, Seattle, Washington. University of Washington School of Medicine, Seattle, Washington. srh@fhcrc.org., Harris WP; Fred Hutchinson Cancer Research Center, Seattle, Washington. University of Washington School of Medicine, Seattle, Washington., Beck JT; Highlands Oncology Group, Fayetteville, Arkansas., Berdov BA; Medical Radiological Research Center, Obninsk, Russian Federation., Wagner SA; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana., Pshevlotsky EM; Omsk Regional Budget Medical Institution: Clinical Oncological Center, Omsk, Russian Federation., Tjulandin SA; Russian Oncology Research Center n.a. N.N. Blokhin, Moscow, Russian Federation., Gladkov OA; Chelyabinsk Regional Clinical Oncology Center, Chelyabinsk, Russian Federation., Holcombe RF; Icahn School of Medicine at Mt. Sinai, New York, New York., Korn R; Imaging Endpoints, Scottsdale, Arizona., Raghunand N; Moffitt Cancer Center, Tampa, Florida., Dychter S; Halozyme Therapeutics, San Diego, California., Jiang P; Halozyme Therapeutics, San Diego, California., Shepard HM; Halozyme Therapeutics, San Diego, California., Devoe CE; Hofstra North Shore-LIJ School of Medicine, Hempstead, New York.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Jun 15; Vol. 22 (12), pp. 2848-54. Date of Electronic Publication: 2016 Jan 26.